{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "329",
                "356"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Regularne przyjmowanie leku"
        },
        {
            "identifier": "T2",
            "position": [
                "358",
                "365"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Tritace"
        },
        {
            "identifier": "T3",
            "position": [
                "366",
                "395"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "1x dziennie 1 tabletka po 5mg"
        },
        {
            "identifier": "T4",
            "position": [
                "396",
                "439"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "Systematyczna kontrola ci\u015bnienia t\u0119tniczego"
        },
        {
            "identifier": "T5",
            "position": [
                "560",
                "567"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Tritace"
        },
        {
            "identifier": "T6",
            "position": [
                "706",
                "717"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "diagnostyki"
        },
        {
            "identifier": "T7",
            "position": [
                "718",
                "730"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "nadci\u015bnienia"
        },
        {
            "identifier": "T8",
            "position": [
                "795",
                "809"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "lek\u00f3w na sta\u0142e"
        },
        {
            "identifier": "T9",
            "position": [
                "810",
                "823"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "nie otrzymuje"
        },
        {
            "icd": "ICD10:I10",
            "identifier": "N1",
            "referenced": "T7",
            "subtype": "Reference",
            "type": "N",
            "value": "Nadci\u00c5\u009bnienie samoistne (pierwotne)"
        },
        {
            "arg1": "T2",
            "arg2": "T3",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T9",
            "arg2": "T8",
            "identifier": "R4",
            "subtype": "Neg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 16 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nZalecenia\n------------------------------------------------\nRegularne przyjmowanie leku:\nTritace 1x dziennie 1 tabletka po 5mg\nSystematyczna kontrola ci\u015bnienia t\u0119tniczego.\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nTritace\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nskierowany do diagnostyki nadci\u015bnienia , podwy\u017cszone warto\u015bci zauwa\u017cono od X 2017, dotychczas zdrowy , lek\u00f3w na sta\u0142e nie otrzymuje\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:7.21[10\\\\^3/ul]\n    RBC:5.59[10\\\\^6/ul]\n    HGB:15.8[g/dl]\n    HCT:44.1[%]\n    MCV:78.9[fl]\n    MCH:28.3[pg]\n    MCHC:35.8[g/dl]\n    PLT:280.0[10\\\\^3/ul]\n    RDW-SD:33.8[fl]\n    RDW-CV:11.9[%]\n    PDW:15.3[fl]\n    MPV:11.7[fl]\n    P-LCR:39.2[%]\n    PCT:0.3[%]\n    NEUTR#:3.68[10\\\\^3/ul]\n    NEUTR%:51.0[%]\n    LYMPH#:2.66[10\\\\^3/ul]\n    LYMPH%:36.9[%]\n    MONO#:0.59[10\\\\^3/ul]\n    MONO%:8.20[%]\n    EO#:0.25[10\\\\^3/ul]\n    EO%:3.50[%]\n    BASO#:0.03[10\\\\^3/ul]\n    BASO%:0.40[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nChemia Kliniczna: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:192.0[ng/ml]\nFibrynogen (F): FIB:2.44[g/L]\nAntytrombina III (ATIII): ATIII:103.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:35.0[s]\nINR: INR:1.1\nCzas protrombinowy (PT): PT:12.6[s]\nCzas trombinowy (TT): TT:14.0[s]\nKwas mlekowy: LAC:28.70[mg/dl]\nKwas mlekowy: LAC:105.40[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:85[%]\nKreatynina: CREA:0.80[mg/dl]\nMocznik: UREA:26.00[mg/dl]\nASPAT: AST:24.00[IU/L]\nALAT: ALT:32.00[IU/L]\nPLT z morfologii: PLT:280.0[10\\\\^3/ul]\nTSH: TSH:2.79[uIU/ml]\nPosiew - Wymaz z nosa: POSIEW:\nPosiew - Wymaz z odbytu: POSIEW:\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:91.9[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:178[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:122.4[ml/min/1,73m2]\nFT3 III: FT3 III:4.20[pg/ml]\nFT4II: FT4II:1.50[ng/dl]\n------------------------------------------------\nICD10\n------------------------------------------------\nI10\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n89.41\n89.541\n88.751\n------------------------------------------------"
}